No differences were observed in IL-6 + B-effs within total B lymphocytes and early-stage B cell subsets (naive B cells, natural effector cells) from smokers without airway obstruction and COPD patients, compared to healthy controls. This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.